BIOMARIN PHARMACEUTICAL INC (BMRN) revenue & profit
BIOMARIN PHARMACEUTICAL INC (BMRN): revenue $3.2B, net income $348.9M in 2025; latest quarter +19.9% year over year. From SEC filings.
$3.2BRevenue 2025
TickerBMRN (Nasdaq)
IndustryOther
Revenue 2025$3.2B
Net income 2025$348.9M
Net margin10.8%
Annual revenue growth+12.9%
Latest quarter (2026 Q2) · Revenue$989.7M
vs. same quarter last year+19.9%
Latest quarter · Net income$44.8M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $2.1B | $141.6M | |
| 2023 | $2.4B | $167.6M | |
| 2024 | $2.9B | $426.9M | |
| 2025 | $3.2B | $348.9M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.